Title : Once-daily vs twice-daily tacrolimus for de novo living kidney transplantation patients including ABO/HLA compatible and incompatible: A randomized trial.

Pub. Date : 2018 Dec

PMID : 30318624






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Tacrolimus (TAC) is available as a twice-daily capsule (TAC-BID), once-daily capsule (TAC-QD), and once-daily tablet. Tacrolimus BH3 interacting domain death agonist Homo sapiens